JP2022538797A5 - - Google Patents

Info

Publication number
JP2022538797A5
JP2022538797A5 JP2021573887A JP2021573887A JP2022538797A5 JP 2022538797 A5 JP2022538797 A5 JP 2022538797A5 JP 2021573887 A JP2021573887 A JP 2021573887A JP 2021573887 A JP2021573887 A JP 2021573887A JP 2022538797 A5 JP2022538797 A5 JP 2022538797A5
Authority
JP
Japan
Application number
JP2021573887A
Other languages
Japanese (ja)
Other versions
JPWO2020252375A5 (https=
JP2022538797A (ja
JP7772597B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037579 external-priority patent/WO2020252375A1/en
Publication of JP2022538797A publication Critical patent/JP2022538797A/ja
Publication of JPWO2020252375A5 publication Critical patent/JPWO2020252375A5/ja
Publication of JP2022538797A5 publication Critical patent/JP2022538797A5/ja
Application granted granted Critical
Publication of JP7772597B2 publication Critical patent/JP7772597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021573887A 2019-06-14 2020-06-12 生物学的送達ビヒクルのための組成物及び方法 Active JP7772597B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962861852P 2019-06-14 2019-06-14
US62/861,852 2019-06-14
US201962948095P 2019-12-13 2019-12-13
US62/948,095 2019-12-13
PCT/US2020/037579 WO2020252375A1 (en) 2019-06-14 2020-06-12 Compositions and methods for biological delivery vehicles

Publications (4)

Publication Number Publication Date
JP2022538797A JP2022538797A (ja) 2022-09-06
JPWO2020252375A5 JPWO2020252375A5 (https=) 2023-07-10
JP2022538797A5 true JP2022538797A5 (https=) 2023-07-10
JP7772597B2 JP7772597B2 (ja) 2025-11-18

Family

ID=73781318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573887A Active JP7772597B2 (ja) 2019-06-14 2020-06-12 生物学的送達ビヒクルのための組成物及び方法

Country Status (8)

Country Link
US (1) US20220296516A1 (https=)
EP (1) EP3982932A4 (https=)
JP (1) JP7772597B2 (https=)
CN (1) CN114286671A (https=)
AU (1) AU2020290516B2 (https=)
CA (1) CA3142949A1 (https=)
IL (1) IL288755A (https=)
WO (1) WO2020252375A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166783B (zh) 2018-10-09 2024-10-11 不列颠哥伦比亚大学 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法
US20230023615A1 (en) * 2019-12-13 2023-01-26 Dnalite Therapeutics, Inc. Compositions and methods for biological delivery vehicles
EP4259099A1 (en) * 2020-12-14 2023-10-18 Particella, Inc. Biological delivery systems
WO2022260678A1 (en) * 2021-06-11 2022-12-15 Dnalite Therapeutics, Inc. Compositions and methods for biological delivery vehicles
JPWO2022176953A1 (https=) * 2021-02-17 2022-08-25
WO2022211481A1 (ko) * 2021-04-01 2022-10-06 에스엔제이 파마 인크 생활성물질의 경구용 나노입자 및 이의 제조방법
KR102789632B1 (ko) * 2021-04-01 2025-04-01 에스엔제이 파마 인크 생활성물질의 경구용 나노입자 및 이의 제조방법
WO2023182812A1 (ko) * 2022-03-22 2023-09-28 주식회사 바이오엔 담즙산염 및 양이온성 펩타이드를 포함하는 단백질 전달용 조성물 및 이의 용도
CN117247359A (zh) * 2022-06-09 2023-12-19 中国科学院广州生物医药与健康研究院 一种树状样脂质化合物、脂质体、脂质复合物、脂质纳米颗粒及其应用
WO2024006863A1 (en) * 2022-06-30 2024-01-04 Precision NanoSystems ULC Lipid nanoparticle formulations for vaccines
CN118356505A (zh) * 2023-01-10 2024-07-19 复旦大学 含末端羟基的peg化纳米载体在制备规避人体预存抗peg抗体的药物制剂中的用途
AU2023457271A1 (en) * 2023-06-28 2025-12-18 Global Life Sciences Solutions Canada Ulc Lipid nanoparticle formulations for cell therapy and related methods
WO2025021286A1 (en) * 2023-07-23 2025-01-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. A drug delivery system for increased endosomal escape
WO2025036297A1 (zh) * 2023-08-11 2025-02-20 浙江海昶生物医药技术有限公司 一种具有靶向性的脂质组合物及其制备方法
US20250082776A1 (en) * 2023-08-31 2025-03-13 Massachusetts Institute Of Technology Polyanion coated lipid nanoparticles and methods of use thereof
PL248770B1 (pl) * 2023-11-23 2026-01-26 Politechnika Wroclawska Bilosomy o dodatnim ładunku i sposób ich wytwarzania
WO2025151073A1 (en) * 2024-01-10 2025-07-17 Agency For Science, Technology And Research Composition and nanoparticle suitable for use in the delivery of a therapeutic agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100817024B1 (ko) * 2006-11-09 2008-03-26 재단법인 목암생명공학연구소 핵산 또는 약물을 간에 특이적으로 전달하는 복합체 및이를 포함하는 약학적 조성물
WO2010149785A1 (en) 2009-06-26 2010-12-29 Universiteit Gent Cationic liposomes for the delivery of high molecular weight compounds
CA2784568A1 (en) 2009-12-18 2011-06-23 The University Of British Columbia Lipid particles for delivery of nucleic acids
WO2012113803A1 (en) * 2011-02-22 2012-08-30 Leo Pharma A/S A cyclic peptide and conjugate thereof for binding to keratinocytes
ES2929516T3 (es) * 2014-10-31 2022-11-29 Univ Utah Res Found Composiciones y métodos para partículas con ácidos biliares
US11219634B2 (en) * 2015-01-21 2022-01-11 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
BR112019008481A2 (pt) * 2016-10-26 2020-03-03 Curevac Ag Vacinas de mrna de nanopartículas lipídicas
EP3558356A2 (en) * 2016-12-23 2019-10-30 CureVac AG Mers coronavirus vaccine
WO2019046809A1 (en) * 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022538797A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
JPWO2022176953A1 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)